Richard Curry

Rindopepimut with temozolomide for patients with newly diagnosed, EGFRvIII-expressing glioblastoma (ACT IV): a randomised, double-blind, international phase 3 trial

Michael Weller, Nicholas Butowski, David Tran et al. · The Lancet Oncology · 2017 · 1.1K citations

Egfrviii-expressing Glioblastoma, Neuro-oncology, Act Iv +10

Rituximab, Methotrexate, Procarbazine, and Vincristine Followed by Consolidation Reduced-Dose Whole-Brain Radiotherapy and Cytarabine in Newly Diagnosed Primary CNS Lymphoma: Final Results and Long-Term Outcome

Patrick G. Morris, Denise D. Correa, Joachim Yahalom et al. · Journal of Clinical Oncology · 2013 · 476 citations · Full text

Pesticide Occurrence in Selected South Florida Canals and Biscayne Bay during High Agricultural Activity

Jennifer A. Harman‐Fetcho, Cathleen J. Hapeman, Laura L. McConnell et al. · Journal of Agricultural and Food Chemistry · 2005 · 65 citations

Night Migrant Fatalities and Obstruction Lighting at Wind Turbines in North America

Paul Kerlinger, Joelle Gehring, Wallace P. Erickson et al. · The Wilson Journal of Ornithology · 2010 · 56 citations

Human Migration, Night Migrant Fatalities, Wind Turbines +7

Safety, tolerability, and pharmacokinetics of anti-EGFRvIII antibody–drug conjugate AMG 595 in patients with recurrent malignant glioma expressing EGFRvIII

Mark Rosenthal, Richard Curry, David A. Reardon et al. · Cancer Chemotherapy and Pharmacology · 2019 · 52 citations

Neuro-oncology, Oncology, Recurrent Malignant Glioma +9